Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the
Central District of California on behalf of investors that purchased Innate Pharma S.A. (NASDAQ: IPHA) securities between March 10, 2020 and September 8, 2020 (the “Class Period”). Investors have
until December